SWZ Swiss Helvetia Fund Inc

THE SWISS HELVETIA FUND, INC.
Schedule of Investments by Industry (Unaudited)																										September 30, 2023
(continued)
1 Non-income producing security.
2 Value determined using significant unobservable inputs.
3 Illiquid. There is not a public market for these securities in the United States or in any foreign jurisdiction, including Switzerland. Securities are priced
at Fair Value in accordance with the Fund’s valuation policy and procedures. At the end of the period, the aggregate Fair Value of these securities amounted
to $2,417,387 or 2.06% of the Fund’s net assets. Additional information on these securities is as follows:
Security										Acquisition Date																				Cost
Aravis Biotech II, Limited Partnership										July 31, 2007 – May 29, 2018																				$	213,885
Eyesense AG – Common Shares										July 22, 2010 – October 3, 2011																					3,007,048
SelFrag AG – Class A – Preferred Shares										December 15, 2011 – January 28, 2014																					1,932,198
Spineart SA – Common Shares										December 22, 2010 - December 20, 2020																					1,554,486
																														$	6,707,617
4 Affiliated Company. An affiliated company is a company in which the Fund has ownership of at least 5% of the company’s outstanding voting
securities or an equivalent interest in the company. Details related to affiliated company holdings are as follows:
																						Change in
		Value				Gross				Gross				Corporate				Realized				Unrealized				Interest				Value
Name of Issuer		as of 12/31/22				Additions				Reductions				Actions				Gain/(Loss)				Gain/(Loss)				Income				as of 9/30/23
Aravis Biotech II, Limited Partnership		$	1,302,142			$	-			$	-			$	(1,814,239	)		$	217,940			$	1,397,566			$	-			$	1,103,409
		$	1,302,142			$	-			$	-			$	(1,814,239	)		$	217,940			$	1,397,566			$	-			$	1,103,409
5 All of the Fund’s investments and other assets are pledged as collateral in accordance with a credit agreement with U.S. Bank, National Association.
See Notes to Schedule of Investments

PORTFOLIO HOLDINGS
% of Net Assets as of September 30, 2023
Pharmaceuticals			22.98	%
Food			21.75	%
Insurance			9.64	%
Healthcare - Products			6.02	%
Retail			5.62	%
Diversified Financial Services			3.53	%
Banks			3.35	%
Biotechnology			3.05	%
Private Equity			2.82	%
Building Materials			2.79	%
Electronic Components & Equipment			2.07	%
Electric			2.01	%
Computers			1.93	%
Industrials			1.73	%
Transportation			1.65	%
Chemicals			1.59	%
Packaging & Containers			1.44	%
Metal Fabricate/Hardware			1.10	%
Healthcare - Services			0.71	%
Machinery-Diversified			0.59	%
Advertising			0.47	%
Semiconductors			0.39	%
Industrial Goods & Services			0.03	%
Other Assets Less Liabilities			2.74	%
			100.00	%

TOP 10 PORTFOLIO HOLDINGS
% of Net Assets as of September 30, 2023
Nestle SA			18.74	%
Novartis AG			12.44	%
Roche Holding AG			10.54	%
Cie Financiere Richemont SA			4.50	%
Zurich Insurance Group AG			4.47	%
UBS Group AG			2.93	%
Partners Group Holding AG			2.82	%
Swiss Life Holding AG			2.20	%
Baloise Holding AG			2.17	%
Aryzta AG			2.16	%

 

THE SWISS HELVETIA FUND, INC.

 

Notes to Schedule of Investments (Unaudited)

 

Various inputs are used to determine the value of the Fund’s investments. These inputs are summarized in the three broad levels listed below:

Level 1—unadjusted quoted prices in active markets for identical assets and liabilities

Level 2—other significant observable inputs (including quoted prices of similar securities, interest rates, prepayment speeds, credit risk, etc.)

Level 3—significant unobservable inputs (including the Fund’s own assumptions in determining the fair value of investments)

 

The inputs or methodology used for valuing securities are not an indication of the risk associated with investing in those securities.

 

The following is a summary of the inputs used to value the Fund’s investments as of September 30, 2023:

TOPIC 820 TABLE
Investments in Securities*		Level 1 Quoted Prices				Level 2 Other Significant Observable Inputs				Level 3 Significant Unobservable Inputs				Investments Valued at NAV**				Total
Common Stock		$	111,687,229			$	-			$	1,279,485			$	-			$	112,966,714
Preferred Stock			-				-				34,493				-				34,493
Limited Partnership			-				-				-				1,103,409				1,103,409
Total Investments in Securities		$	111,687,229			$	-			$	1,313,978			$	1,103,409			$	114,104,616

 

**   As of September 30, 2023, certain of the Fund’s investments were valued using net asset value (“NAV”) per share (or its equivalent) as a practical expedient for fair value and have been excluded from the fair value hierarchy in accordance with ASU 2015-07. The fair value amount presented in this table is intended to permit reconciliation of the amounts presented in the fair value hierarchy to the amounts presented in the schedule of investments.

 

The Fund values its investment in a private equity limited partnership in accordance with Accounting Standards Codification 820-10-35, “Investments in Certain Entities that Calculate Net Asset Value Per Share (Or its Equivalent)” (“ASC 820-10-35”). ASC 820-10-35 permits a reporting entity to measure the fair value of an investment that does not have a readily determinable fair value, based on the NAV of the investment as a practical expedient, without further adjustment, unless it is probable that the investment will be sold at a value significantly different than the NAV. If the NAV of the investment is not as of the Fund’s measurement date, then the NAV should be adjusted to reflect any significant events that may change the valuation. Inputs and valuation techniques for these adjustments may include fair valuations of the partnership and its portfolio holdings provided by the partnership’s general partner or manager, other available information about the partnership’s portfolio holdings, values obtained on redemption from other limited partners, discussions with the partnership’s general partner or manager and/or other limited partners and comparisons of previously-obtained estimates to the partnership’s audited financial statements. In using the unadjusted NAV as a practical expedient, certain attributes of the investment that may impact its fair value are not considered. Attributes of those investments include the investment strategies of the privately held companies and may also include, but are not limited to, restrictions on the investor’s ability to redeem its investments at the measurement date and any unfunded commitments.

Level 3 securities, which are listed in Note 3 to the Schedule of Investments, consist of the Fund’s investments in privately-held companies.

 

Inputs and valuation techniques used by the Fund to value its Level 3 investments in privately-held companies may include the following: acquisition cost; fundamental analytical data; discounted cash flow analysis; nature and duration of restrictions on disposition of the investment; public trading of similar securities of similar issuers; economic outlook and condition of the industry in which the issuer participates; financial condition of the issuer; and the issuer’s prospects, including any recent or potential management or capital structure changes. Although these valuation inputs may be observable in the marketplace as is characteristic of Level 2 investments, the privately-held companies, categorized as Level 3 investments, generally are highly illiquid in terms of resale.

 

When valuing Level 3 investments, management also may consider potential events that could have a material impact on the operations of a privately-held company. Not all of these factors may be considered or available, and other relevant factors may be considered on an investment-by-investment basis.

The following is a reconciliation of Level 3 assets for which significant unobservable inputs were used to determine fair value.

LEVEL 3 ROLLFORWARD TABLE
		Common Stock				Preferred Stock				Total
Balance as of December 31, 2022		$	1,384,260			$	48,722			$	1,432,982
Change in Unrealized Appreciation/Depreciation (a)			(104,775	)			(14,229	)			(119,004	)
Net Realized Gain (Loss)			-				-				-
Gross Purchases			-				-				-
Gross Sales			-				-				-
Transfer out of Level 3			-				-				-
Balance as of September 30, 2023		$	1,279,485			$	34,493			$	1,313,978
Change in unrealized appreciation (depreciation) during the period for Level 3 investments held at September 30, 2023			(104,775	)			(14,229	)			(119,004	)

 

(a)	The noted amounts of change in unrealized appreciation/depreciation relate to the fair value of Level 3 assets held on September 30, 2023.

Swiss Helvetia (NYSE:SWZ)
Historical Stock Chart
From Oct 2024 to Nov 2024

Swiss Helvetia (NYSE:SWZ)
Historical Stock Chart
From Nov 2023 to Nov 2024